
Subtitle: How p57 immunohistochemistry separates a complete mole from a partial mole and a hydropic abortus: the genetics, the histology, how to read the stain, a diagnostic algorithm, pitfalls, virtual slides and 10 MCQs.
Author: PathologyMCQ Editorial Board
Category: Gynaecological and Placental Pathology
Last Updated: October 2026
Read Time: 9 minutes
At-a-Glance
- p57 (CDKN1C) is paternally imprinted and maternally expressed, so it marks tissue that contains a maternal genome.
- Complete mole is androgenetic: villous cytotrophoblast and stromal cells are p57 negative.
- Partial mole and non-molar gestations both contain a maternal genome and are p57 positive; genotyping separates them.
- Read it correctly: ignore syncytiotrophoblast (always negative) and confirm the internal control in decidua or extravillous trophoblast.
Molar pregnancy is a form of gestational trophoblastic disease divided into complete and partial hydatidiform moles. The distinction matters because complete moles carry a much higher risk of persistent disease. Morphology alone can be difficult, especially early in gestation, and p57 immunohistochemistry is the most useful routine test.
Why p57 Works: The Genetics
p57 (CDKN1C) is a cyclin-dependent kinase inhibitor encoded on chromosome 11p15.5. The gene is paternally imprinted (the paternal allele is silenced) and maternally expressed. So p57 protein appears only in cells that carry a maternal genome.

Androgenetic diploid
46,XX (usually one sperm duplicated in an empty ovum) or 46,XY (two sperm).
p57 lostDiandric triploid
69,XXY, 69,XXX or 69,XYY: two paternal sets and one maternal.
p57 retainedBiparental diploid
Normal or trisomic conceptus, including hydropic abortion.
p57 retainedPaternal set Maternal set

Histology of Complete and Partial Moles
Complete hydatidiform mole
- Diffusely enlarged, oedematous villi with central cisterns.
- Circumferential trophoblastic hyperplasia, often with atypia.
- Scalloped villous outlines; villous blood vessels and fetal parts are absent.
- Early complete mole (first trimester): bulbous, polypoid villi, hypercellular myxoid stroma with karyorrhectic debris and labyrinthine canaliculi, often without cisterns.
- Atypical implantation site with exaggerated, atypical extravillous trophoblast.

Partial hydatidiform mole
- Two populations of villi: large irregular villi with cisterns and small fibrotic villi.
- Irregular scalloped outlines with trophoblastic pseudoinclusions.
- Focal, mild trophoblastic hyperplasia.
- Fetal tissue or villous vessels with nucleated red cells may be present.

| Feature | Complete mole | Partial mole | Hydropic abortus |
|---|---|---|---|
| Genome | Androgenetic diploid | Diandric triploid | Biparental diploid |
| Villi | Diffusely enlarged, cisterns | Two populations | Rounded, mildly hydropic |
| Trophoblast | Circumferential hyperplasia | Focal, mild hyperplasia | Polar, not hyperplastic |
| Outline | Scalloped | Scalloped, pseudoinclusions | Smooth |
| Fetal tissue | Absent | May be present | May be present |
| p57 (villous cytotrophoblast and stroma) | Negative | Positive | Positive |
Virtual Slides
What to look for
Drag to pan ยท pinch or double-tap to zoom ยท use the + / โ buttons
How to Read p57
Complete mole: p57 negative
- Villous cytotrophoblast: negative.
- Villous stromal cells: negative.
- Decidua and extravillous (intermediate) trophoblast: positive, acting as the internal control.

Partial mole: p57 positive
- Villous cytotrophoblast: positive.
- Villous stromal cells: positive.
- Decidua and extravillous trophoblast: positive.
- The same pattern is seen in non-molar gestations, so a positive result does not prove a partial mole.

Summary Table: Interpreting p57
| Compartment | Complete mole | Partial mole | Non-molar gestation |
|---|---|---|---|
| Villous cytotrophoblast | Negative | Positive | Positive |
| Villous stromal cells | Negative | Positive | Positive |
| Syncytiotrophoblast | Negative | Negative | Negative |
| Extravillous trophoblast | Positive (control) | Positive | Positive |
| Decidua | Positive (control) | Positive | Positive |


Diagnostic Algorithm
Pitfalls in p57 Interpretation
Clinical Relevance
- p57 is most valuable when morphology cannot separate a complete mole from a partial mole or hydropic abortion.
- About 15โ20% of complete moles progress to gestational trophoblastic neoplasia, compared with about 0.5โ5% of partial moles.
- The diagnosis determines serial beta-hCG monitoring after evacuation.
Test Yourself: 10 MCQs
p57 and molar pregnancy: 10 MCQs
Imprinting, morphology, staining patterns and pitfalls. Tap an answer for the explanation.
More practice: the gynaecological pathology MCQ bank โ
Exam Pearls
- p57 = maternal genome marker: complete mole negative, partial mole and non-molar positive.
- Read villous cytotrophoblast and stroma; syncytiotrophoblast is always negative.
- Decidua and extravillous trophoblast are the internal positive controls.
- Positive p57 does not prove a partial mole; genotyping separates it from a hydropic abortus.
- Discordant staining suggests a twin or mosaic gestation.
Featured course
Read every placental and gynae biopsy with a plan
Learn a pattern-based approach to products of conception, the endometrium and gynaecological tumours, so you know when a stain like p57 is needed.
Pattern-based approaches for gynaecological pathology and every system
- Low-power algorithms for villi, endometrium and trophoblast
- Slide videos that walk you from pattern to diagnosis
- Built by practising pathologists for sign-out and exams
More courses
Preparing for an exam?
The Pathology MCQ app
A slide and an MCQ every day
Daily MCQ with streaks, pinch-zoom virtual slides with annotations, and your courses in one place.
Related reads: Gynaecological pathology MCQs (WHO 6th edition) โ
References
- Kurman RJ, Ellenson LH, Ronnett BM. Blausteinโs Pathology of the Female Genital Tract. 7th edition. Springer; 2019.
- Banet N, DeScipio C, Murphy KM, et al. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping. Mod Pathol. 2014;27:238โ254.
- WHO Classification of Tumours Editorial Board. Female Genital Tumours. 5th edition. IARC; 2020.



Leave a Reply